Conditions: Asthma
Keywords: asthma Fluticasone furoate GW642444
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 243
Healthy volunteers: no

Brief summary:
The primary purpose of the study is to assess the safety and tolerability of 52-week teatment with fluticasone furoate/GW642444 inhalation powder once-daily and FF inhalation powder once-daily in Japanese adult subjects with asthma.

Detailed description:

Arms:
arm 1: Combination inhaled corticosteroid and long-acting beta2-agonist arm 2: Inhaled corticosteroid

Interventions: intervention 1: Fluticasone Furoate/GW642444 Inhalation Powder intervention 2: Fluticasone Furoate Inhalation Powder
Intervention descriptions: intervention 1: Fluticasone Furoate/GW642444 inhalation powder inhaled orally once daily for 52 weeks intervention 2: Fluticasone Furoate inhalation powder inhaled orally once daily for 52 weeks

Protocol document: